Abbott Laboratories
ABT
$133.22
Share price
-0.10%
Change (1 day)
31.07%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Revenue for Abbott Laboratories (ABT)
Revenue in 2025 (TTM): $42.34 Billion USD
According to Abbott Laboratories's latest financial reports the company's current revenue (TTM 
) is $42.34 Billion USD. In 2024 the company made a revenue of $41.95 Billion USD an increase over the revenue in the year 2023 that were of $40.10 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Abbott Laboratories from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $42.34 B | 0.94% |
| 2024 | $41.95 B | 4.59% |
| 2023 | $40.10 B | -8.12% |
| 2022 | $43.65 B | 1.34% |
| 2021 | $43.07 B | 24.47% |
| 2020 | $34.60 B | 8.48% |
| 2019 | $31.90 B | 4.34% |
| 2018 | $30.57 B | 11.64% |
| 2017 | $27.39 B | 31.35% |
| 2016 | $20.85 B | 2.2% |
| 2015 | $20.40 B | 1.11% |
| 2014 | $20.18 B | -5.27% |
| 2013 | $21.30 B | -20.21% |
| 2012 | $26.69 B | -31.28% |
| 2011 | $38.85 B | 10.48% |
| 2010 | $35.16 B | 14.31% |
| 2009 | $30.76 B | 4.19% |
| 2008 | $29.52 B | 13.94% |
| 2007 | $25.91 B | 18.47% |
| 2006 | $21.87 B | -2.08% |
| 2005 | $22.33 B | 13.51% |
| 2004 | $19.68 B | 6.46% |
| 2003 | $18.48 B | 4.53% |
| 2002 | $17.68 B | 8.59% |
| 2001 | $16.28 B | 18.47% |
| 2000 | $13.74 B | 3.94% |
| 1999 | $13.22 B | 5.98% |
| 1998 | $12.47 B | 5% |
| 1997 | $11.88 B | 7.9% |
| 1996 | $11.01 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $89.33 B | 110.96% | 🇺🇸 USA |
 Pfizer PFE | $62.46 B | 47.51% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $42.89 B | 1.31% | 🇺🇸 USA |
 Hologic HOLX | $4.02 B | -90.49% | 🇺🇸 USA |
 Medtronic MDT | $33.53 B | -20.80% | 🇮🇪 Ireland |
 Bristol-Myers Squibb BMY | $47.63 B | 12.50% | 🇺🇸 USA |
 Boston Scientific BSX | $17.55 B | -58.55% | 🇺🇸 USA |
 AstraZeneca AZN | $54.98 B | 29.85% | 🇬🇧 UK |
 Novartis NVS | $53.22 B | 25.69% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $40.58 B | -4.15% | 🇬🇧 UK |